Showing results (461-470 of 480) with videos related to
Sort By:
Pageof 48
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2012
Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2024
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])Charles E Geyer, Joanne L Blum, Greg Yothers, et al.Breast Cancer Research : BCR|October 22, 2009
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen, Sean Brummel, Yuan Chun Ding, et al.Cell|October 22, 2016
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsIuliia Gilchuk, Pavlo Gilchuk, Gopal Sapparapu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)Joanne L Blum, Patrick J Flynn, Greg Yothers, et al.JAMA|September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortalitySusan M Domchek, Tara M Friebel, Christian F Singer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 29, 2011
Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen, Sean Brummel, Yuan Chun Ding, et al.Cancer Research|July 9, 2009
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriersTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.Molecular Cancer Therapeutics|November 23, 2012
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilitiesDavid W Craig, Joyce A O'Shaughnessy, Jeffrey A Kiefer, et al.Pageof 48